Market Analysis for 5EU Drug (Parkinson’s Disease) to 2022

1
PharmaPoint Parkinsons Disease 5EU Drug
Forecast and Market Analysis to 2022
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_marketoptimizer.org with
your contact details and questions if any.

• Published Mar 2014
• Single User PDF US 6995
• Corporate User PDF US 20985

2
PharmaPoint Parkinsons Disease 5EU Drug
Forecast and Market Analysis to 2022

• Parkinsons disease is a progressive condition
  that is characterized by bradykinesia, muscular
  rigidity, tremor, and postural instability. As
  the second most common neurodegenerative
  disorder, Parkinsons disease may affect
  individuals of any age but prevalence is
  increased with age and it is most common in the
  elderly. Dopaminergic therapies have been fairly
  effective in treating bradykinesia, but several
  unmet needs remain. Some needs will be met during
  the forecast period from 2012-2022, while others,
  such as the need for disease-modifying drugs,
  will remain. GlobalData expects that advancements
  will be made in levodopa administration and that
  four new molecular entities will be introduced to
  the market by 2022, these factors along with
  increased patient numbers from an aging
  population will drive the market during the
  forecast period.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
3
PharmaPoint Parkinsons Disease 5EU Drug
Forecast and Market Analysis to 2022

• Although France has a lower-than-average rate of
  generic substitution compared with other parts of
  Europe, increasing pressures from its aging
  population and increased disease burden are
  forcing governments to institute cost-saving
  measures. The market leader therapies in Germany
  are all no longer patent protected and include
  the class of oral dopamine agonists. While the
  overall pharmaceutical market in Italy is
  shrinking, the medical device market in Italy is
  growing. This market growth will be driven by six
  new product launches, and by an aging population,
  resulting in an increased prevalence of
  Parkinsons disease in Spain. Population growth
  and the aging population will continue to build
  steady growth in the UK Parkinsons disease
  market and six additional product launches,
  including the introduction of A2A antagonists in
  2019, will bring in an extra 24.7m in sales in
  2022.
• Inquire about this report at http//www.marketopti
  mizer.org/contacts/purchase?rname7280

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
4
PharmaPoint Parkinsons Disease 5EU Drug
Forecast and Market Analysis to 2022

• Scope
• Overview of Parkinsons Disease including
  epidemiology, etiology, symptoms, diagnosis,
  pathology and treatment guidelines as well as an
  overview on the competitive landscape.
• Detailed information on the key drugs in 5EU
  including product description, safety and
  efficacy profiles as well as a SWOT analysis.
• Sales forecast for the top drugs in 5EU from
  2012-2022.
• Analysis of the impact of key events as well the
  drivers and restraints affecting the 5EU
  Parkinsons Disease market.
• Get a detailed report at http//www.marketoptimiz
  er.org/pharmapoint-parkinsons-disease-5eu-drug-for
  ecast-and-market-analysis-to-2022.html .

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
5
PharmaPoint Parkinsons Disease 5EU Drug
Forecast and Market Analysis to 2022

• Reasons to buy
• Understand and capitalize by identifying products
  that are most likely to ensure a robust return
• Stay ahead of the competition by understanding
  the changing competitive landscape for
  Parkinsons Disease
• Effectively plan your MA and partnership
  strategies by identifying drugs with the most
  promising sales potential
• Make more informed business decisions from
  insightful and in-depth analysis of drug
  performance
• Obtain sales forecast for drugs from 2012-2022 in
  5EU
•  
• Contact sales_at_marketoptimizer.org with subject
  line PharmaPoint Parkinsons Disease 5EU Drug
  Forecast and Market Analysis to 2022 and your
  contact details to purchase this report or get
  your questions answered. OR Call 1 888 391 5441.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
6
PharmaPoint Parkinsons Disease 5EU Drug
Forecast and Market Analysis to 2022

• About Us
• marketoptimizer.org is an online market research
  reports library of 250,000 in-depth studies of
  over 5000 micro markets. Our database includes
  reports by leading publishers from across the
  globe. We provide 24/7 online and offline support
  service to our customers. marketoptimizer.org
  also offers company data, country profiles,
  trends, information and analysis on the sector of
  your interest.
• Visit Us _at_
• http//www.marketoptimizer.org
• Follow Us

Call Now 1 888 391 5441 Email sales _at_
sales_at_marketoptimizer.org